TumorGraft3D Platform

Champions offers platforms for ex vivo drug testing in matrix-free multiclonal 3D organ-like tumor cultures derived from our patient-derived xenograft (PDX) models.

These clinically relevant models enable the rapid development of high throughput ex vivo assays using cytotoxicity readouts, high content imaging, and molecular endpoints to support preclinical research and de-risk in vivo studies, furthering traditional and immuno-oncology studies.